Litcius/Paper detail

Methylxanthines as Potential Inhibitor of SARS-CoV-2: an In Silico Approach

Rajan Rolta, Deeksha Salaria, Bhanu Sharma, Oladoja Awofisayo, Olatomide A. Fadare, Sonum Sharma, Chirag Patel, Vikas Kumar, Anuradha Sourirajan, David J. Baumler, Kamal Dev

2022Current Pharmacology Reports27 citationsDOIOpen Access PDF

Topics & Concepts

AutoDockTheophyllineTheobromineIn silicoChemistrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PharmacologyDocking (animal)Ligand (biochemistry)BiochemistryCoronavirus disease 2019 (COVID-19)BiologyMedicineReceptorGenePathologyInfectious disease (medical specialty)DiseaseNursingComputational Drug Discovery MethodsSARS-CoV-2 and COVID-19 ResearchMetabolomics and Mass Spectrometry Studies
Methylxanthines as Potential Inhibitor of SARS-CoV-2: an In Silico Approach | Litcius